IJCRR - 6(15), August, 2014
SURGICAL MANAGEMENT OF GINGIVAL ENLARGEMENT: A CASE SERIES
Author: Munaza shafi, Nawal khan, Prabhati Gupta, Reyaz Ahmed Mir, Nasrina Bashir
Introduction: Gingival enlargement is defined as an overgrowth or increase in size of gingiva. Gingival enlargement is associated with multiple factors including inflammation, medications, neoplasia, hormonal disturbances and heredity. A case of gingival enlargement should be treated in a step-wise manner, including consultation with the patient’s physician, substitution of the drug, nonsurgical therapy, surgical therapy (if needed), and supportive periodontal therapy after every 3 months. Case series: This case series presents diagnosis and management of amlodipine induced gingival hyperplasia and idiopathic gingival enlargement. Drug-induced gingival enlargement and idiopathic gingival enlargement was diagnosed and managed byscaling and root planing followed by gingivectomy with 6 months follow up Conclusion: Conventional gingivectomy with oral hygiene measures and regular followup is the treatment of choice for such
Keywords: Drug- induced enlargement, idiopathic gingival enlargement, gingivectomy
Munaza shafi, Nawal khan, Prabhati Gupta, Reyaz Ahmed Mir, Nasrina Bashir. SURGICAL MANAGEMENT OF GINGIVAL ENLARGEMENT: A CASE SERIES International Journal of Current Research and Review. 6(15), August, 53-56
1. Brunet Ll, Miranda J, Farré M et al. Gingival enlargement induced by drugs. Drug Saf 1996; 15(3): 219–231.
2. Clocheret K, Dekeyser C, Carels C et al. Idiopathic gingival hyperplasia and orthodontic treatment: a case report. J Orthod 2003; 30(1): 13–19. |
3. Rodríguez Y, Baena R, Rizzo S et al. Mandibular traumatic peripheral osteoma: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112(6): 44–48.
4. Seymour RA, Ellis JS, Thomson JM. Pathogenesis of drug inducedgingival overgrowth. J Clin Periodontol 1996;23:165-75.
5. K. Kavvadia, E. Pepelassi, C. Alexandridis, A. Arkadopoulou, G. Polyzois, and K. Tossios, “Gingival fibromatosis and significant tooth eruption delay in an 11-year-old male: a 30-month followup,” International Journal of Paediatric Dentistry, vol. 15, no. 4, pp. 294–302, 2005.
6. Lafzi A, Farahani RM, Shoja MA. Amlodipine induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal. 2006;11:E480–2.
7. Brown RS, Sein P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia.First case report. Oral Surg Oral Med Oral Pathol. 1990;70:593–6
8. Nyska A, Shemesh M, Tal H, Dayan D. Gingival hyperplasia induced by calcium-channel blockers: Mode of action. Med Hypotheses. 1994;43:115–8
9. Das SJ, Olsen I. Keratinocyte growth factor is upregulated by hyperpla-sia-inducing drug nifedipine. Cytokine. 2000;12:1566–9
10. leuten CJ, Trijbels-Smeulders MA, van de Kerkhof PC. Telan-giectasia and gingival hyperplasia as side-effects of amlodipine (Norvasc) in a 3-year-old girl. Acta Derm Venereol. 1999;79:323–4.
11. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286–92
12. N. Gagliano, C. Moscheni, C. Dellavia et al., “Morphological and molecular analysis of idiopathic gingival fibromatosis: a case report,” Journal of Clinical Periodontology, vol. 32, no. 10, pp. 1116–1121, 2005.
13. Shirasuna K, Okura M, Watatani K, Hayashido Y, Saka M, Matsuya T. Abnormal cellular property of fibroblasts from congenital gingival fibromatosis. J Oral Pathol 1988;17:381-5
14. De Andrade CR, Cotrin P, Graner E, Almeida OP, Sauk JJ, Coletta RD. Transforming growth factor-beta 1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis. J Periodontol 2001;72:1726-33
15. Coletta RD, Reynolds MA, Martelli-Junior H, Graner E, Almeida OP, Sauk JJ. Testosterone stimulates proliferation and inhibits interleukin-6 production of normal and hereditary gingival fibromatosis fibroblasts. Oral Microbiol Immunol 2002;17:186- 92.